Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.

OBJECTIVES The International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) have collaborated to propose a new pathologic classification of lung adenocarcinoma. In this classification, noninvasiveness and invasiveness have been newly defined for lung adenocarcinoma. The aims of this study were to validate the prognostic significance of tumor invasiveness as defined by the new IASLC/ATS/ERS classification and to assess the relationship between pathologic invasiveness and radiologic findings in pathologic stage IA lung adenocarcinoma. METHODS We retrospectively reviewed 123 consecutive patients with pathologic stage IA lung adenocarcinoma. Pathologic data were classified according to the new IASLC/ATS/ERS classification. The following radiologic parameters were assessed using thin-section computed tomography: the ground-glass opacity ratio, tumor disappearance rate, and consolidation diameter. RESULTS There were 54 noninvasive and 69 invasive adenocarcinomas. Five-year overall survival rates for noninvasive adenocarcinoma and invasive adenocarcinoma were 100% and 78.4%, respectively; this difference was statistically significant (P < .01), indicating the prognostic value of this classification. Receiver operating characteristic curves of the ground-glass opacity ratio, tumor disappearance rate, and consolidation diameter identified the optimal cut-off values for predicting the presence of invasive tumors as 50%, 75%, and 10 mm, respectively. CONCLUSIONS We found that by using the new IASLC/ATS/ERS classification, histologic subtypes of pathologic stage IA lung adenocarcinoma with prognostic value could be identified. Tumor invasiveness of lung adenocarcinoma as defined by this classification can be predicted by evaluating the ground-glass opacity ratio, tumor disappearance rate, and consolidation diameter on thin-section computed tomography.

[1]  Y. Nishiwaki,et al.  Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. , 2000, The Annals of thoracic surgery.

[2]  M. Tsuboi,et al.  Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification. , 2013, Clinical radiology.

[3]  A. Kirschbaum,et al.  Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[5]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  K. Mori,et al.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. , 2002, The Journal of thoracic and cardiovascular surgery.

[7]  Y. Kato,et al.  Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma. , 2008, Chest.

[8]  Morihito Okada,et al.  Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. , 2011, The Journal of thoracic and cardiovascular surgery.

[9]  M. Okada,et al.  Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. , 2004, The Journal of thoracic and cardiovascular surgery.

[10]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[11]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[12]  K. Eguchi,et al.  Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. , 2003, The Annals of thoracic surgery.

[13]  T. Kohno,et al.  Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. , 2007, The Journal of thoracic and cardiovascular surgery.

[14]  G. Watanabe,et al.  Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. , 2001, The Annals of thoracic surgery.

[15]  H. Ohmatsu,et al.  Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. , 2005, The Journal of thoracic and cardiovascular surgery.

[16]  Ken Kodama,et al.  Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. , 2006, The Journal of thoracic and cardiovascular surgery.

[17]  Kotaro Kameyama,et al.  Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. , 2009, The Journal of thoracic and cardiovascular surgery.

[18]  A. Akobeng,et al.  Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.

[19]  K Kuriyama,et al.  Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. , 1999, AJR. American journal of roentgenology.

[20]  Akihiko Yoshizawa,et al.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.

[21]  Yoichi Kameda,et al.  Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. , 2007, The Annals of thoracic surgery.

[22]  A. Borczuk,et al.  Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma , 2009, The American journal of surgical pathology.

[23]  Kenji Suzuki,et al.  Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. , 2001, The Journal of thoracic and cardiovascular surgery.

[24]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.